Sermorelin is a growth hormone releasing hormone analog that signals your pituitary gland to produce and release growth hormone naturally -- restoring what age suppressed, not replacing it with synthetic alternatives. Prescribed. Compounded. Delivered monthly.
Individual results vary and are not guaranteed. Data reflects published research, not AnthologyRX-specific outcomes. All patients require physician evaluation before any prescription is issued.
Sermorelin is a synthetic analog of growth hormone releasing hormone (GHRH) -- the peptide your hypothalamus naturally produces to signal your pituitary gland to release growth hormone. It is not synthetic human growth hormone. It does not introduce exogenous GH into your body. It restores the upstream signal that triggers your own pituitary to produce and release GH as it did earlier in life.
This distinction matters clinically. Exogenous HGH bypasses the body's natural feedback loop, suppressing pituitary function over time. Sermorelin works with the hypothalamic-pituitary-somatotropic axis, not around it -- preserving the natural pulsatility that regulates how and when growth hormone is released. Growth hormone secretion occurs in pulses, not continuously, and maintaining that architecture is central to how the protocol works.
Growth hormone production begins declining in your 30s -- approximately 14% per decade. By 40, most adults have lost a measurable portion of the GH output they had at peak. Sermorelin is prescribed and managed by a licensed physician. Compounded by a licensed 503B pharmacy. Delivered monthly -- if approved after clinical review.
Not synthetic HGH.
A signal to your pituitary
to produce GH naturally.
Preserves the feedback loop.
Pulses preserved.
The axis intact.
Subcutaneous injection.
Prescribed, not purchased.
Provider-guided protocol.
A single, precisely formulated peptide -- compounded by a licensed 503B pharmacy and prescribed by a board-certified provider after clinical review.
Prescription issued subject to provider judgment. Results vary. Not a guarantee of outcomes. Compounded Sermorelin is not an FDA-approved drug product.
Growth hormone plays a central role in lipolysis -- the breakdown of stored fat for energy -- and in supporting lean muscle tissue. As GH output declines with age, the body's tendency to shift toward higher fat mass and lower lean mass increases. Sermorelin-stimulated GH secretion supports the metabolic pathways that govern body composition, particularly in adults who are already training and eating well but not seeing results consistent with their effort. Changes are gradual and require sustained protocol adherence. Individual outcomes vary; provider assessment determines candidacy.
The majority of daily growth hormone secretion occurs during slow-wave (deep) sleep -- not during waking hours. Age-related GH decline correlates directly with a reduction in slow-wave sleep quality. Patients on Sermorelin protocols frequently report meaningful improvements in sleep depth and morning recovery well before other changes become apparent. Better GH pulsatility supports deeper sleep; deeper sleep supports GH release -- the relationship is bidirectional. Your provider evaluates sleep history at intake and monitors reported changes at monthly check-ins.
Growth hormone is directly involved in tissue repair, protein synthesis, and the recovery mechanisms that follow physical demand. Athletes and active adults experiencing longer recovery windows, persistent soreness, or a plateau in training adaptation often present with GH output patterns consistent with age-related decline. Sermorelin-supported GH secretion addresses the upstream hormone signal that governs these repair processes. Recovery improvements tend to emerge gradually over the first two to three months; individual response varies and outcomes are not guaranteed.
Growth hormone receptors are present throughout the brain, and GH deficiency in adults is associated with reduced cognitive performance, energy, and motivation in clinical literature. GH also plays a role in insulin sensitivity and glucose metabolism. Patients on provider-guided Sermorelin protocols report improvements in mental clarity, sustained energy, and overall metabolic efficiency -- though individual response varies significantly and no specific outcome is guaranteed. Your provider reviews your full clinical picture before issuing any prescription.
Your training volume is consistent. Your nutrition is dialed. But your body no longer bounces back the way it did at 28. Recovery that used to take 24 hours now takes 48. If nothing has changed except the decade, age-related GH decline is a clinically supported contributor. Sermorelin protocols are provider-evaluated based on your full intake; not every candidate is a match.
You're in a caloric structure that should work. The training is there. But fat loss has stalled, and lean mass isn't responding the way it once did. When lifestyle fundamentals are in place and results still plateau, GH-related metabolic decline is worth evaluating. Sermorelin supports the hormonal environment where body composition changes are possible -- it does not guarantee them.
You're getting hours -- but not depth. You wake unrefreshed. Sleep tracking shows shallow cycles. Poor sleep architecture is both a symptom and a driver of GH decline. Sermorelin's relationship with deep sleep is one of the most consistent findings in the patient experience -- improvements in sleep quality are often the first reported change, emerging in the first four to six weeks for many patients.
Sermorelin is frequently evaluated alongside NAD+ for patients pursuing comprehensive longevity and performance optimization. The mechanisms complement each other -- Sermorelin supports the GH axis and anabolic recovery environment, while NAD+ addresses cellular energy production and DNA repair. Your physician reviews all active protocols at intake and sequences them appropriately. Stacking is case-by-case, never automatic.
Your intake screens for all contraindications. Every candidate is evaluated by a licensed physician before any prescription is issued. If your clinical picture requires additional review, your provider will advise you directly -- no prescription is issued without clearance.
A structured medical questionnaire covering your health history, current medications, sleep quality, recovery patterns, body composition goals, and contraindication screening. Under five minutes. No video call required. Completed entirely on your schedule.
A board-certified physician reviews your intake within 48 hours. They evaluate your candidacy for Sermorelin, screen for contraindications including thyroid status and prior pituitary history, and issue your prescription if approved. If not approved, you receive clinical reasoning and are not charged.
Your Sermorelin is compounded by a licensed 503A & 503B pharmacy under cGMP standards and shipped directly to your door. Injection supplies are included. No pharmacy visit. No insurance required. Temperature-controlled where indicated.
Monthly provider check-ins and dosing titration based on your response. Sermorelin protocols are typically evaluated at 90 days for meaningful response assessment. Direct messaging access to your care team throughout. Active management, not auto-pilot.
I've tracked my sleep for three years. Within five weeks of starting Sermorelin, my deep sleep numbers shifted more than anything I'd tried before. I'm waking up differently. That was the first thing -- before body comp, before anything else.
I was training like I was 35 but recovering like I was 52. Four months in, that gap has closed significantly. My coach noticed it before I said anything. I'm stacking training weeks I couldn't have managed before. The consistency is what changed -- not just the peak days.
As a physician, I was skeptical of the body comp claims. Three months in, my lean mass has shifted and my recovery window has shortened meaningfully -- despite a training block I'd normally struggle to complete. The data is what convinced me. I wasn't expecting the magnitude of the change.
Individual results vary and are not typical. Testimonials reflect patient-reported outcomes and are used for illustrative purposes only. Results are not guaranteed. All patients are under licensed physician supervision. Outcomes are not representative of the typical patient experience.
The discipline is there. The effort is there. But if your pituitary isn't getting the upstream signal it once did, the recovery environment you need to build on that effort won't be there. Sermorelin restores the signal.
Start Assessment →Subscriptions renew monthly. Cancel anytime before your renewal date -- no fees, no calls required. Provider review is required before any prescription is issued. All treatments require physician approval. Results vary. FSA/HSA eligibility depends on your individual plan. Compounded Sermorelin is not an FDA-approved drug product.
Synthetic human growth hormone (HGH) introduces exogenous GH directly into the body -- bypassing the hypothalamic-pituitary axis entirely. Over time, this suppresses the pituitary's own production and disrupts the natural feedback loop. Sermorelin works differently. It is an analog of growth hormone releasing hormone (GHRH) -- the signal your hypothalamus naturally sends to your pituitary to produce GH. Rather than replacing GH, it restores the upstream signal, allowing the pituitary to produce and release GH in its natural pulsatile pattern. This preserves the feedback architecture that governs how, when, and how much GH is released. The clinical implication: Sermorelin supports a more physiologically appropriate GH response and carries a different risk profile than direct HGH administration. Your provider reviews both your goals and medical history to determine which approach is appropriate for you -- if any.
Sermorelin is not an acute compound -- it works by progressively restoring the hormonal environment, not by producing an immediate effect. Sleep quality improvements are typically reported first, often within four to six weeks. Recovery changes and energy improvements tend to follow in the two-to-three-month range. Body composition shifts -- particularly changes in lean mass and fat distribution -- require sustained protocol adherence and are typically meaningful at the three-to-four month mark. Protocols are generally evaluated at 90 days for a meaningful assessment of response. Response timelines vary significantly by individual and are not guaranteed. Your provider will check in monthly and adjust dosing based on your progress.
Sermorelin is administered as a subcutaneous injection -- the same technique used for insulin. The standard clinical protocol calls for administration at bedtime, as this aligns with the body's natural GH secretion window during deep sleep. Injecting at night supports the physiological pulsatile pattern rather than disrupting it. Your first shipment includes detailed injection instructions and all necessary supplies: vials, syringes, and alcohol prep pads. Subcutaneous injection involves a small needle introduced just under the skin -- typically in the abdomen or thigh -- at a shallow angle. Most patients are comfortable with the technique within the first one to two self-administrations. Your care team is available via direct message if you have any questions after receiving your supplies.
Lab work is not universally required before starting Sermorelin, but your provider may request baseline labs based on your intake responses and health history. For patients with thyroid concerns, a history of pituitary conditions, or other relevant findings, your provider may require specific labs before issuing a prescription -- thyroid function, in particular, is reviewed as untreated hypothyroidism can blunt the GH response. If you have recent bloodwork, sharing it during intake is useful context. Your physician makes the individual determination about what additional screening is needed -- it is not a standardized requirement across all patients. If labs are requested, your provider will advise you directly.
Sermorelin is frequently evaluated alongside NAD+ for patients pursuing comprehensive longevity and performance optimization. The mechanisms are complementary -- Sermorelin supports the GH axis and the anabolic recovery environment, while NAD+ addresses cellular energy production and DNA repair at the mitochondrial level. Your physician reviews all active medications, supplements, and protocols at intake and evaluates compatibility on a case-by-case basis. Stacking is never automatic -- it requires clinical clearance based on your individual picture. Disclose all current treatments during your intake so your provider can design the appropriate protocol sequence for your goals and health history.
Compounded Sermorelin, as provided through AnthologyRX, is not an FDA-approved drug product. Compounded medications are prepared by licensed compounding pharmacies under applicable federal and state regulations and are prescribed on the basis of individual patient need by a licensed physician. Compounding is a legal and established medical practice that allows licensed pharmacies to prepare customized formulations not available commercially. The FDA does not evaluate compounded medications for safety, efficacy, or quality in the same manner it does for FDA-approved drug products. Your provider will discuss the regulatory status and clinical considerations with you as part of their evaluation.
Your intake takes five minutes. Provider review within 48 hours. No waiting room. No contracts. No guesswork. Prescription issued if approved -- compounded and delivered monthly.
